Year Experience of A Tertiary Referral Allergy Centre. Asthma Allergy Immunology, 20(1), 3647., Doi: 10.21911/aai.647 | | |
Öztop Nida, Beyaz Şengül, Örçen Cihan. Abdominal Obesity and Metabolic Parameters in Chronic Spontaneous Urticaria. Medical Bulletin of Haseki, 60(3), 263-269. doi: 10.4274/haseki.galenos.2022.8399 | 2022 | Sorumlu araştırmacı |
Beyaz S, Demir S, Oztop N, Colakoglu B, Buyukozturk S, Gelincik A. How satisfactory is on-demand icatibant from the patients' perspective in real life? Allergy Asthma Proc. 2022 Mar 1;43(2):148-154. doi: 10.2500/aap.2022.43.210104. | 2022 | Yardımcı araştırmacı |
Cakmak ME, Öztop N, Yeğit OO, Özdedeoğlu Ö. Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study. Int Arch Allergy Immunol. 2023;184(8):736-743. doi: 10.1159/000529760. | 2023 | Yardımcı araştırmacı |
Cakmak ME, Öztop N, Yeğit OO, Özdedeoğlu Ö. Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or nonsuper-responder to omalizumab treatment: a single-center real-life study. J Asthma. 2023 Oct;60(10):1862-1868. doi: 10.1080/02770903.2023.2196562 | 2023 | Yardımcı araştırmacı |
Cakmak ME, Yegit OO, Öztop N. A Case-Control Study Comparing the General Characteristics of Patients with Symptomatic Dermographism and Chronic Spontaneous Urticaria: Is Atopy a Risk Factor for Symptomatic Dermographism? Int Arch Allergy Immunol. 2023 Dec 12:1-6. doi: 10.1159/000535290. | 2023 | Yardımcı araştırmacı |
Cakmak ME, Öztop N, Yeğit OO. Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment: A Real-Life Study. Int Arch Allergy Immunol. 2023 Nov 22:1-9. doi: 10.1159/000534907. | 2023 | Yardımcı araştırmacı |
Yeğit OO, Aslan AF, Coşkun R, Karadağ P, Toprak İD, Can A, Öztop N, Demir S, Ünal D, Olgaç M, Gelincik A. Comparison of recent anaphylaxis diagnostic criteria in real life: Can more patients be diagnosed as having anaphylaxis? World Allergy Organ J. 2023 Aug 26;16(8):100810. doi: 10.1016/j.waojou.2023.100810. | 2023 | Yardımcı araştırmacı |
Cakmak ME, Yeğit OO, Öztop N. Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study. Int Arch Allergy Immunol. 2023;184(3):236-242. doi: 10.1159/000528048. | 2023 | Yardımcı araştırmacı |
Beyaz Ş, Belkaya S, Öztop N. Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria. Allergol Immunopathol (Madr). 2023 Jul 1;51(4):87-93. doi: 10.15586/aei.v51i4.894. | 2023 | Yardımcı araştırmacı |
Öztop N, Beyaz Ş. The effect of stress on the onset of chronic spontaneous urticaria in the elderly. Alergologia Polska-Polish Journal of Allergology. 2023;10(1):57-62. doi:10.5114/pja.2023.125769. | 2023 | Sorumlu araştırmacı |
Toprak İlkim Deniz, Demir Semra, Oztop Nida, Aslan Ayşe Feyza, Unal Derya, Gelincik Aslı. Post‐COVID‐19 Vaccination Trimester Evaluation in Mastocytosis: A Single‐Center Real‐Life Experience. Asthma Allergy Immunol 2023;21:226-236. Doi: 10.21911/aai.364 | 2023 | Yardımcı araştırmacı |
Paçacı Çetin G, Kepil Özdemir S, Can Bostan Ö, Öztop N, Çelebi Sözener Z, Karakaya G, Gelincik Akkor A, Yılmaz İ, Mungan D, Bavbek S. Ağır astım tedavisinde biyolojikler: Güncel durum raporu 2023 [Biologics for the treatment of severe asthma: Current status report 2023]. Tuberk Toraks. 2023 Jun;71(2):176-187. Turkish. doi: 10.5578/tt.20239921. | 2023 | Yardımcı araştırmacı |
Yegit OO, Karadağ P, Eyice D, Oztop N, Beyaz Ş, Tüzer ÖC, Can A, Demir S, Erdoğdu D, İşsever H, Genç S, Ömer B, Jolles S, Gelincik Akkor A. Calculated Globulin Is Clinically Useful as a Screening Test for Antibody Deficiency in Turkish | 2023 | Yardımcı araştırmacı |
Adult Patients. Int Arch Allergy Immunol. 2023;184(8):822-831. doi: 10.1159/000528986. | | |
Olgaç M, Yeğit OO, Beyaz Ş, Öztop N, Tüzer C, Eyice D, Karadağ P, Coşkun R, Demir S, Çolakoğlu B, Büyüköztürk S, Gelincik A. Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment. An Bras Dermatol. 2023 Mar-Apr;98(2):189-197. doi: 10.1016/j.abd.2022.08.006. | 2023 | Yardımcı araştırmacı |
Oztop N, Vitus MV, Faihs V, Kugler C, Biedermann T, Brockow K. Test Panel of Hidden Allergens for "Idiopathic Anaphylaxis" Reveals Wheat Allergy Dependent on Augmentation Factors as Common Final Diagnosis. J Allergy Clin Immunol Pract. 2024 Sep;12(9):2337-2346. doi: 10.1016/j.jaip.2024.05.037. | 2024 | Sorumlu araştırmacı |
Demir S, Eyice-Karabacak D, Kocatürk E, Ünal D, Toprak İD, Korkmaz P, Aslan AF, İmren IG, Dikicier B, Kahveci N, Öztop N, Kara RÖ, İşsever H, Maurer M, Weller K, Gelincik A. Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study. Clin Transl Allergy. 2024 Mar;14(3):e12342. doi: 10.1002/clt2.12342. | 2024 | Yardımcı araştırmacı |
Unal D, Demir S, Işik SR, Olgaç M, Coşkun R, Terzioğlu K, Ersoy R, Beyaz Ş, Öztop N, Tüzer C, Yeğit OO, Karsli S, Işsever H, Gelincik A, Çolakoğlu B, Büyüköztürk S. Impact of providing education on the recognition and differential diagnosis of angioedema among emergency department physicians. World Allergy Organ J. 2025 Aug 9;18(8):101101. doi: 10.1016/j.waojou.2025.101101. | 2025 | Yardımcı araştırmacı |
Kilavuz H, Gungor F, Yaman S, Oztop N, Demir M, Kurtulus I. Identification of drug and food allergy in surgery clinic: Automation system and red wristband combination. Medicine (Baltimore). 2025 Jun 20;104(25):e42963. doi: 10.1097/MD.0000000000042963. | 2025 | Yardımcı araştırmacı |
Cakmak ME, Oztop N. Delayed pressure urticaria successfully treated with omalizumab: A tertiarylevel health-care center experience. Allergy Asthma Proc. 2025 Jul 1;46(4):323-327. doi: | 2025 | Yardımcı araştırmacı |